Introduction
Adenosine triphosphate is the most important molecule for energy storage in vivo. Adenosine triphosphate also plays an important role in the central nervous system. The role of adenosine triphosphate as a neurotransmitter in the nervous system was first reported in 1959 (Holton, 1959) , and a diverse set of physiological actions by adenosine triphosphate have been revealed (Butt, 2011) . Astrocytes release adenosine triphosphate to propagate an intercellular calcium wave (Cotrina et al., 1998; Guthrie et al., 1999) , and the released adenosine triphosphate is also important in triggering cellular responses to trauma and ischemia (Burnstock, 2006; Franke et al., 2014) . In addition, adenosine triphosphate stimulates astrocyte proliferation and contributes to the process of reactive astrogliosis (Ambrosini et al., 1994) . Besides these functions, adenosine triphosphate is also involved in the regulation of neuronal excitability, initiation of pain, and mediation of intercellular communication (Cook et al., 1997; Avshalumov et al., 2005; Gomes et al., 2005) . In the nervous system, adenosine triphosphate is an extracellular signaling molecule that is mainly released from exocytotic vesicles, and the concentration of nucleotides in such vesicles can reach 1,000 mmol/L. The released adenosine triphosphate is transported to the synaptic cleft, and selectively acts on receptors to perform its functions, which include neurotransmitter regulation, synaptic modification, and neurotrophy (Hernández, 1992; Froemke et al., 2006) . Under normal physiological conditions, the concentration of extracellular adenosine triphosphate is relatively low (Illes et al., 2004; Köles et al., 2011) . However, mechanical stress, hypoxia, inflammation, and certain agonists can lead to a massive release of adenosine triphosphate (Bodin et al., 2001) . When the extracellular concentration of adenosine triphosphate reaches a certain level, secondary neuronal death occurs (Skaper et al., 2010) . The main source of adenosine triphosphate acting on purinoceptors was reported as deriving from damaged or dying cells (Burnstock, 2006) . Therefore, research on the toxic effects of adenosine triphosphate on neurons may help to elucidate the process of neuronal death and provide new ideas for therapies targeting brain injury.
Human neuroblastoma cells SH-SY5Y were originally isolated from the neural crest during nervous development. They exhibit similar biochemical, pharmacological, and functional characteristics to neurons and are considered to be a good in vitro model for studying neuronal function, differentiation, and apoptosis. Autophagy, discovered after necrosis and apoptosis, is a third form of cell death. Prior research showed that autophagy has cerebral protective effects. When neurons are stressed, autophagy is first activated. When autophagy cannot maintain a steady state, cell apoptosis occurs, and finally necrosis. In the present study, SH-SY5Y cells were incubated in different concentrations of adenosine triphosphate for different lengths of time. After treatment, cell viability, autophagy, and apoptosis were measured. In addition, the expressions of Bcl-2, Bax, and Beclin 1 were also assessed. We hypothesized that autophagy removes and degrades damaged organelles to satisfy the metabolic demands of cells, as well as protect them (Zou et al., 2012) .
Materials and Methods
Cell culture SH-SY5Y cells were purchased from the Cell Bank, Chinese Academy of Sciences, Shanghai, China. The human neuroblastoma SH-SY5Y cell line was cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT, USA) at 37°C with 5% CO 2 . The medium was replaced every 48 hours. The cells were passaged until cell fusion occurred. Treatments were performed on cells in the logarithmic growth phase in this study.
Experimental groups
(1) Primary SH-SY5Y cell cultures were treated for 3 hours with one of six different concentrations of adenosine triphosphate as follows: DMEM control group; DMEM + adenosine triphosphate (Sigma, St Louis, MO, USA) at 2 mmol/L; DMEM + adenosine triphosphate at 4 mmol/L; DMEM + adenosine triphosphate at 6 mmol/L; DMEM + adenosine triphosphate at 8 mmol/L; or DMEM + adenosine triphosphate at 10 mmol/L. (2) Primary SH-SY5Y cell cultures were treated with adenosine triphosphate at 6 mmol/L for different lengths of time as follows: DMEM control group (no adenosine triphosphate) or DMEM + adenosine triphosphate at 6 mmol/L for 1, 2, 3, or 6 hours.
Morphological examination
After treatment with different adenosine triphosphate concentrations (2, 4, 6, 8, or 10 mmol/L for 3 hours) and different exposure times (1, 2, 3, or 6 hours) of 6 mmol/L adenosine triphosphate, the morphology of the SH-SY5Y cells was observed with an inverted optical microscope.
Cell Counting Kit assay SH-SY5Y cells were first thawed and seeded into 96-well plates at a density of 5 × 10 7 cells/well (100 μL). After being cultured in an incubator for 24 hours, the cell media were aspirated and replaced with new media containing different concentrations of adenosine triphosphate (2, 4, 6, 8, 10 mmol/L) for 3 hours. The serum-containing medium without adenosine triphosphate was used as a control (n = 8) (Wei et al., 2013) .
The cell viability was assessed using a Cell Counting Kit-8 (CCK-8) kit (Guangzhou Jing Xin Biological Technology Co., Ltd., China), and the absorbance values were measured using a microplate reader at 570 nm. This experiment was performed in triplicate.
Cell viability was calculated as the absorbance adenosine triphosphate / absorbance control × 100%, where absorbance is the mean value from five replicates, absorbance control is the control group absorbance, and absorbance adenosine triphosphate is the treatment group absorbance values.
Similarly, the effects of incubation time (1, 2, 3, or 6 hours) (Wei et al., 2013) at 6 mmol/L adenosine triphosphate on cell viability were also determined.
Monodansylcadaverine staining for autophagic vacuoles
Monodansylcadaverine staining was performed as previously described (Pamenter et al., 2012) . Briefly, the cells were treated with 6 mmol/L of adenosine triphosphate for 1, 2, 3, or 6 hours. Then, 0.05 mmol/L monodansylcadaverine was added, and the cells were incubated at 37°C for another 60 minutes. After removing the monodansylcadaverine, the cells were fixed in 4% paraformaldehyde for 5 minutes at 4°C. Finally, the samples were observed using fluorescence microscopy (BX51 Olympus, Tokyo, Japan; excitation wavelength: 365 nm; blocking wavelength: 430 nm). Five randomly selected microscopic fields at 400 × magnification were used to quantify the fluorescence intensity with Image J software (National Institutes of Health, Bethesda, MD, USA), which represents the relative levels of cellular autophagy. The average fluorescence values were calculated from three biological replicates.
Detection of cell apoptosis
Flow cytometry (EPICS® ALTRA™; Olympus) was performed on cells treated with 6 mmol/L adenosine triphosphate for 1, 2, 3, or 6 hours. The cells were stained with propidium iodide at 1 μg/mL and Annexin V-FITC for 15 minutes at 37°C, and then the samples were washed twice with PBS. A minimum of 10,000 cells were collected for each sample, and the data were analyzed using FCS Express Flow Cytometry software (De Novo Software, Los Angeles, CA, USA). The flow cytometry software was used to directly calculate the percentage of apoptotic cells. The average % of apoptotic cells was calculated from three biological replicates.
Real-time PCR (RT-PCR)
RT-PCR was performed on cells after treatment with 6 mmol/L adenosine triphosphate for 1, 2, 3, or 6 hours. We performed the total RNA extraction using Trizol reagent (Invitrogen, Guangzhou, China). Reverse transcriptases (Life Technolo-gies) were used to prepare complementary DNA according to the manufacturer's instructions. The expression levels were quantified on the ABIPR ISM 7500 system (Applied Biosystems, Foster City, CA, USA) using the SYBR Green I dye method (Toyobo, Shanghai, China). The expression levels of Bcl-2, Bax, and Beclin 1 were detected by PCR using the specific primers shown in Table 1 . β-Actin was used as a control. The PCR program consisted of 95°C for 30 seconds, and then 40 cycles of 95°C for 5 seconds and 60°C for 34 seconds. The mRNA relative expression levels (2 -△△ Ct ) were calculated using a previous method (Li et al., 2013) .
Western blot assay
Western blot assay was performed on the same samples used for RT-PCR analysis. The SH-SY5Y cells were separated into five groups (the same for groups in experimental groups (2)): (1) control group, (2) adenosine triphosphate incubation 1-hour group, (3) adenosine triphosphate incubation 2-hour group, (4) adenosine triphosphate incubation 3-hour group, and (5) adenosine triphosphate incubation 6-hour group. Western blot assay was performed using standard protocols. The cells were first lysed on ice with phenylmethyl sulfonylfluoride lysis buffer (Applygen Technologies Inc., Beijing, China) for 30 minutes. The lysed cells were collected by centrifugation at 12,000 × g for 5 minutes at 4°C to obtain the total protein, which was then quantified using the bicinchoninic acid protein assay (ShineGene, Shanghai, China). A total of 50 μg of protein was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis on 5-10% gels, and then transferred to nitrocellulose membranes. The membranes were blocked with 5% powdered skim milk in Tris-buffered saline with Tween (10 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 0.05% Tween-20) and incubated overnight with rabbit anti-human Bcl-2, rabbit anti-human Bax (1:1,000; Abcam, Cambridge, UK), rabbit anti-human Beclin 1 (1:1,000; Abgent Biotechnology, San Diego, CA, USA), or mouse anti-human GAPDH (1:3,000, Abgent Biotechnology) antibodies at 4°C. After washing, the mem- branes were incubated with horseradish peroxidase-conjugated IgG secondary antibodies (goat anti-rabbit and goat anti-mouse IgG/horseradish peroxidase; 1:1,000; KPL Biotechnology, Gaithersburg, MD, USA) for 1 hour at room temperature and visualized with an enhanced chemiluminescence reagent system (Pierce Biotechnology, Rockford, IL, USA). Grayscale densitometric scanning of the protein bands was performed with Quanti Scan software (National Institutes of Health) using GAPDH as the control. Data were expressed as the absorbance ratio of target protein to GAPDH.
Statistical analysis
Data were expressed as the mean ± SD, and analyzed using SPSS 11.0 software (SPSS, Chicago, IL, USA). One-sample Kolmogorov-Smirnov Z tests were used to determine whether the data were normally distributed before analysis. Comparisons between different groups were performed using one-way analysis of variance, and intragroup comparisons were performed using least significant difference tests. P-values less than 0.05 were considered statistically significant.
Results

Morphology of adenosine triphosphate-treated SH-SY5Y cells
After treatment with different concentrations of adenosine triphosphate for 3 hours or 6 mmol/L adenosine triphosphate for 1, 2, 3, or 6 hours, the morphology of the SH-SY5Y cells was significantly altered. As shown in Figures 1 and 2 , most of the untreated SH-SY5Y cells were spindle-shaped, showing cell processes, strong adherence, and high contrast. In addition, a large number of particles were observed in the cytoplasm. After treatment, however, the cells became round and the numbers of adherent cells, cell processes, cell volume, and contrast were all decreased with increasing concentration of adenosine triphosphate and increased exposure to adenosine triphosphate. These changes indicated that the negative effects of adenosine triphosphate were concentration-and time-dependent.
Cell viability decreased after adenosine triphosphate treatment Cell viability was determined to quantify the damaging effects of adenosine triphosphate on SH-SY5Y cells. After 3 hours of adenosine triphosphate treatment, the cell viabilities were significantly reduced to 81.7 ± 2.1% in 2 mmol/L, 64.2 ± 1.7% in 4 mmol/L, 50.5 ± 2.2% in 6 mmol/L, 30.6 ± 0.9% in 8 mmol/L, and 10.5 ± 0.7% in 10 mmol/L adenosine triphosphate (P < 0.05). These data further illustrate the concentration-dependent effects of adenosine triphosphate on SH-SY5Y cells. The effects of incubation time on cell viability were also analyzed, showing significant reductions in cell viability with time until 3 hours (1 hour: 55.4 ± 2.6%; 2 hours: 42.6 ± 1.3%; and 3 hours: 33.5 ± 0.7%) (P < 0.05). However, no difference was found between treatment for 3 and 6 hours (3 hours: 33.5 ± 0.7%; and 6 hours: 34.1 ± 2.5%). Figure 3 , the fluorescence was significantly enhanced after 1 hour of treatment, as indicated by the appearance of a large number of autophagic vacuoles. However, the fluorescence began to decrease with prolonged treatment time.
Apoptosis increased after adenosine triphosphate treatment
After treatment with adenosine triphosphate, the apoptosis rates of the cells were detected using flow cytometry. As shown in Figure 4 , the mean apoptotic population of normal SH-SY5Y cells was 2.11 ± 0.09%. However, the apoptotic fraction of treated cells was significantly increased in a time-dependent manner. The apoptosis rates were 6.23 ± 0.42% after 1 hour, 9.23 ± 0.21% after 2 hours, 11.60 ± 0.26% after 3 hours, and 30.51 ± 0.19% after 6 hours of treatment.
Adenosine triphosphate altered the expression of Bcl-2, Bax, and Beclin 1 Bcl-2 and Bax are both associated with apoptosis, and Beclin 1 is associated with autophagy. Therefore, we performed RT-PCR and western verification on adenosine triphosphate-treated cells to determine the expression levels of these genes. The expression of Bcl-2 was significantly reduced in treated groups compared with the control group, while the expression of Bax was significantly increased. Beclin 1 exhibited significantly increased levels after 1 hour of treatment. However, it began to decrease at prolonged treatment times ( Figure 5 ).
Discussion
Apoptosis is an active cell death process. In this study, cell viability was significantly decreased in a concentrationand time-dependent manner by adenosine triphosphate treatment. In addition, the apoptosis rate was also significantly increased in a time-dependent manner. These results suggest that the adenosine triphosphate treatment initiated apoptosis in the cells. We also analyzed the expression of (A1-A5) Monodansylcadaverine staining of autophagic vacuoles in SH-SY5Y cells after exposure to 6 mmol/L adenosine triphosphate for 1, 2, 3, and 6 hours. Strong monodansylcadaverine blue fluorescence signal in the cells identified autophagic vacuoles, and the fluorescence was significantly enhanced after an hour of treatment, which indicated the appearance of a large number of autophagic vacuoles. However, the fluorescence began to decline with prolonged treatment times. (B) The fluorescence intensity of monodansylcadaverine in SH-SY5Y cells after exposure to 6 mmol/L adenosine triphosphate for 1, 2, 3, and 6 hours. Data are expressed as the mean ± SD, n = 3. *P < 0.05 vs. the control group; #P < 0.05, vs. the 1-hour group. Comparisons between different groups were performed using one-way analysis of variance, and intragroup comparisons were performed using the least significant difference tests. h: Hour. Compared with the controls, the percentage of apoptotic cells was significantly higher in the other groups after ATP treatment (mean ± SD, n =3, *P < 0.05, vs. control group; #P < 0.05 vs. the 6-hour group). Comparisons between the different groups were performed using one-way analysis of variance, and intragroup comparisons were performed using the least significant difference tests. High expression levels of Bcl-2 and low Bax expression have been reported to induce high rates of apoptosis . These phenomena further demonstrate the effects of adenosine triphosphate at high concentration on apoptosis.
Autophagy is a special form of cell death that is involved in the pathogenesis of brain injuries, neurodegenerative changes, and schizophrenia, among other diseases of the nervous system (Shpilka et al., 2011) . Autophagy removes and degrades damaged organelles to satisfy the metabolic demands of cells, as well as protect them (Zou et al., 2012) . Several external factors have been reported to induce autophagy such as starvation, hypoxia, high temperatures, and cellular stress (Feng et al., 2014) . In the present study, we observed the process of autophagy in SH-SY5Y cells after treatment with adenosine triphosphate. We found that adenosine triphosphate significantly induced a large number of autophagic vacuoles after an hour of treatment. However, the number of autophagic vacuoles began to decline with prolonged treatment times. These changes indicate a positive role for autophagy during the repair of cell damage and these increases in autophagy occurred prior to the apoptosis peak at 6 hours. Further, we analyzed the expression of autophagy-related protein Beclin 1 and found a significantly increased expression level at 1 hour, which decreased over time. Beclin 1 is reported to be an upstream signaling molecule that can activate autophagy. Dissociated Beclin 1 forms a phosphatidylinositol 3-kinase III complex with a variety of proteins to participate in autophagy. In addition, upregulating the expression of Beclin 1 in mammalian cells may induce autophagy (Gabryel et al., 2012) . Therefore, autophagy was likely initiated by the adenosine triphosphate treatment.
Based on our results, we suspect that adenosine triphosphate activates autophagy and apoptosis at the same time. When stress occurs in neurons, autophagy is first activated to protect neurons by maintaining neuronal homeostasis, to (A) Quantification of Bcl-2, Bax, and Beclin 1 mRNA expressions (RT-PCR). Data are expressed as absorbance of target protein to GAPDH. Compared with the untreated control group, Bax mRNA expression was significantly higher after treatment with 6 mmol/L ATP at all time points (P < 0.05). Bax mRNA expression peaked after 3 hours of treatment, while the Bcl-2 mRNA expression was significantly decreased (P < 0.05). Beclin 1 mRNA expression was significantly increased at 1, 2, and 3 hours (P < 0.05), showing the highest level after 1 hour and gradually decreasing with time. *P < 0.05, vs. control group; &P < 0.05, vs. the 1-hour group; #P < 0.05, vs. the 3-hour group. (B) Gel images from the western blots. (C) Quantification of Bcl-2, Bax, and Beclin 1 protein. Western blot assay showed that, compared with the untreated control group, Bax protein expression was significantly higher in all other groups after treatment with 6 mmol/L ATP (P < 0.05). Bax protein expression peaked at 6 hours, while the Bcl-2 expression was significantly decreased (P < 0.05). Beclin 1 protein expression was significantly increased at 1, 2, and 3 hours (P < 0.05), showing the highest level after 1 hour and gradually decreasing with time. *P < 0.05, vs. the control group; &P < 0.05, vs. the 1-hour group; #P < 0.05, vs. the 6-hour group. (A, C) Data were expressed as the mean ± SD. Comparisons between different groups were performed using one-way analysis of variance, and intragroup comparisons were performed the using least significant difference tests. reduce secondary injury, and to remove damaged organelles (Zeng et al., 2012; Zhao et al., 2012) . However, excessive activation of autophagy may lead to apoptosis (Balduini et al., 2012; Pamenter et al., 2012) . The accumulation of autophagic vacuoles appeared before apoptosis and was not affected by apoptosis inhibitors in prior studies. When autophagy was inhibited, the expression of Bcl-2 was also inhibited, though Bax was activated (Fayaz et al., 2014; Lin et al., 2014) . Therefore, autophagy may lose its sensitivity to the adenosine triphosphate antagonist over time, leading to a decline in autophagy and acceleration of apoptosis (Lomonaco et al., 2011; Wang et al., 2012) . In summary, high concentrations of extracellular adenosine triphosphate first induced autophagy, and then led to apoptosis in SH-SY5Y cells. Further research on the regulation of autophagy and apoptosis mechanisms by the gliotransmitter adenosine triphosphate may lead to new ideas for the treatment and repair of neuronal injury.
